We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Eli Lilly And Co | LSE:0Q1G | London | Ordinary Share | ELI LILLY ORD SHS |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | USD 34.12B | USD 5.24B | USD 5.5202 | 167.33 | 77.68B |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
17:09:15 | O | 13 | 71,220.23 | CHF |
Date | Time | Source | Headline |
---|---|---|---|
09/9/2024 | 12:16 | ALNC | Eli Lilly names Lucas Montarce as new chief financial officer |
08/8/2024 | 12:57 | ALNC | TOP NEWS: Eli Lilly lifts guidance as Mounjaro and Zepbound sales jump |
08/7/2024 | 19:58 | ALNC | Eli Lilly weight loss drug beats Ozempic in head-to-head study |
05/6/2024 | 14:00 | ALNC | TOP NEWS: Alphabet poaches Eli Lilly CFO Anat Ashkenazi for same role |
21/5/2024 | 13:14 | ALNC | *Eli Lilly: over half of Crohn's disease patients reach remission at 1 year.. |
15/5/2024 | 21:07 | ALNC | Eli Lilly reaches settlement with Totality Medispa |
30/4/2024 | 13:26 | ALNC | TOP NEWS: Eli Lilly lifts outlook, ramps up production to meet demand |
08/3/2024 | 15:16 | ALNC | Eli Lilly's Donanemab Alzheimer's drug hit by delays |
06/2/2024 | 12:44 | ALNC | TOP NEWS: Eli Lilly eyes beefier sales amid weight loss drug craze |
26/1/2024 | 06:04 | ALNC | Eli Lilly weight loss drug could be supplied to UK 'in weeks' |
Eli Lilly (0Q1G) Share Charts1 Year Eli Lilly Chart |
|
1 Month Eli Lilly Chart |
Intraday Eli Lilly Chart |
Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
---|
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions